Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut
18/06/2025 17:31
June 18 (Reuters) - Caris Life Sciences' CAI.O shares jumped nearly 28.6% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new listings in 2025. (Reporting by Pritam Biswas in Bengaluru; Editing by Shinjini Ganguli) ((Pritam.Biswas@thomsonreuters.com;))
Recent news on Sixth Street Specialty Lending
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Broadening credit concerns driving BDC weakness, KBW says
Brighthouse closes up after report Sixth Street looking to revive bid
Reuters Next: U.S. approach to regulation of AI is problematic, Sixth Street's Chavez says
Sixth Street to buy minority stake in Kpler, valuing the firm at more than $3.7 billion, sources say